Early versus delayed administration of norepinephrine in patients with septic shock

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Bai, Xiaowu ^a   Yu, Wenkui ^a   Ji, Wu ^a   Lin, Zhiliang ^a   Tan, Shanjun ^a   Duan, Kaipeng ^a   Dong, Yi ^a   Xu, Lin ^a   Li, Ning ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; INFUSION FLUID; LACTIC ACID; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; ANTIBIOTIC THERAPY; APACHE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; EARLY INTERVENTION; FEMALE; FLUID RESUSCITATION; HUMAN; HYPOTENSION; INTENSIVE CARE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; ORGAN PERFUSION; PRIMARY INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SURVIVAL RATE; SURVIVOR; THERAPY DELAY; TIME TO TREATMENT; TREATMENT DURATION; AGED; DRUG ADMINISTRATION; HOSPITAL MORTALITY; INTENSIVE CARE UNIT; MIDDLE AGED; SHOCK, SEPTIC; TREATMENT OUTCOME;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NOREPINEPHRINE; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE; TIME-TO-TREATMENT; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84910025786     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0532-y     Document Type: Article

References (23)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
2. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087, 12851245.
3. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250. 10.1097/01.CCM.0000261890.41311.E9, 17414736.
4. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169.
5. Hill SL, Elings VB, Lewis FR. Changes in lung water and capillary permeability following sepsis and fluid overload. J Surg Res 1980, 28:140-150. 10.1016/0022-4804(80)90157-2, 6987463.
6. Sakka SG, Klein M, Reinhart K, Meier-Hellmann A. Prognostic value of extravascular lung water in critically ill patients. Chest 2002, 122:2080-2086. 10.1378/chest.122.6.2080, 12475851.
7. Sandifer JP, Jones AE. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock. Ann Emerg Med 2013, 62:534-535. 10.1016/j.annemergmed.2013.01.031, 23683544.
8. Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Ann Pharmacother 2013, 47:301-310. 10.1345/aph.1R442, 23447481.
9. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265.
10. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
11. Parrillo JE. Septic shock-vasopressin, norepinephrine, and urgency. N Engl J Med 2008, 358:954-956. 10.1056/NEJMe0800245, 18305271.
12. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732. 10.1097/00003246-200008000-00007, 10966242.
13. Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21:1296-1303. 10.1097/00003246-199309000-00011, 8370292.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
16. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
17. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014, 42:1749-1755. 10.1097/CCM.0000000000000330, 24717459.
18. Sennoun N, Montemont C, Gibot S, Lacolley P, Levy B. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 2007, 35:1736-1740. 10.1097/01.CCM.0000269028.28521.08, 17522580.
19. Morimatsu H, Singh K, Uchino S, Bellomo R, Hart G. Early and exclusive use of norepinephrine in septic shock. Resuscitation 2004, 62:249-254. 10.1016/j.resuscitation.2004.03.016, 15294412.
20. Subramanian S, Yilmaz M, Rehman A, Hubmayr RD, Afessa B, Gajic O. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Intensive Care Med 2008, 34:157-162. 10.1007/s00134-007-0862-1, 17924093.
21. Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 2000, 7:83-101. 10.1038/sj.mn.7300096, 10802851.
22. Silverman HJ, Penaranda R, Orens JB, Lee NH. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993, 21:31-39. 10.1097/00003246-199301000-00010, 8380553.
23. Hinder F, Stubbe HD, Van Aken H, Baba HA, Jahn UR, Brodner G, August C, Erren M, Booke M. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med 2003, 31:903-909. 10.1097/01.CCM.0000050289.15988.67, 12627003.